| scholarly article | Q13442814 |
| P50 | author | José Franco da Silveira | Q111118044 |
| P2093 | author name string | Diana Bahia | |
| Renata Watanabe Costa | |||
| P2860 | cites work | Signal transduction in human macrophages by gp83 ligand of Trypanosoma cruzi: trypomastigote gp83 ligand up-regulates trypanosome entry through protein kinase C activation | Q73098076 |
| Lipids shed into the culture medium by trypomastigotes of Trypanosoma cruzi | Q73404734 | ||
| Phospholipase A1 from Trypanosoma cruzi infective stages generates lipid messengers that activate host cell protein kinase c | Q79377210 | ||
| The Genome Sequence of Trypanosoma cruzi, Etiologic Agent of Chagas Disease | Q22065799 | ||
| Functions and mechanisms of action of CCN matricellular proteins | Q24642303 | ||
| Cysteine protease inhibitors cure an experimental Trypanosoma cruzi infection | Q24645720 | ||
| TcTASV-C, a protein family in Trypanosoma cruzi that is predominantly trypomastigote-stage specific and secreted to the medium | Q27309739 | ||
| A novel cell surface trans-sialidase of trypanosoma cruzi generates a stage-specific epitope required for invasion of mammalian cells | Q28323919 | ||
| The Trypanosoma cruzi protease cruzain mediates immune evasion | Q28476751 | ||
| CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes | Q33252349 | ||
| Genomic organization and expression profile of the mucin-associated surface protein (masp) family of the human pathogen Trypanosoma cruzi | Q33425111 | ||
| A Cdc42 activation cycle coordinated by PI 3-kinase during Fc receptor-mediated phagocytosis | Q33623817 | ||
| A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease | Q33760119 | ||
| Stage-specific phospholipase C-mediated release of Trypanosoma cruzi neuraminidase | Q67903391 | ||
| Turnover and shedding of the Tc-85 surface glycoprotein of Trypanosoma cruzi trypomastigotes | Q71336469 | ||
| Oligopeptidase B-dependent signaling mediates host cell invasion by Trypanosoma cruzi | Q33889376 | ||
| A B-cell mitogen from a pathogenic trypanosome is a eukaryotic proline racemase | Q33912838 | ||
| Secretory pathway of trypanosomatid parasites | Q33969495 | ||
| A soluble factor from Trypanosoma cruzi inhibits transforming growth factor-ß-induced MAP kinase activation and gene expression in dermal fibroblasts. | Q34023102 | ||
| A cysteine protease inhibitor protects dogs from cardiac damage during infection by Trypanosoma cruzi. | Q34228426 | ||
| Parasite polyclonal activators: new targets for vaccination approaches? | Q34240147 | ||
| The MASP family of Trypanosoma cruzi: changes in gene expression and antigenic profile during the acute phase of experimental infection | Q34385087 | ||
| A recombinant protein based on Trypanosoma cruzi P21 enhances phagocytosis | Q34516532 | ||
| Extracellular vesicles in parasitic diseases | Q34767634 | ||
| Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells | Q34790521 | ||
| AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer | Q34990362 | ||
| Cell signalling and Trypanosoma cruzi invasion | Q34994362 | ||
| Evidence of reversible bradycardia and arrhythmias caused by immunogenic proteins secreted by T. cruzi in isolated rat hearts | Q35043895 | ||
| Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection. | Q35073839 | ||
| Molecular characterization of Trypanosoma cruzi SAP proteins with host-cell lysosome exocytosis-inducing activity required for parasite invasion | Q35082650 | ||
| Uptake of host cell transforming growth factor-beta by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role in parasite cycle completion. | Q35085273 | ||
| Differential expression and characterization of a member of the mucin-associated surface protein family secreted by Trypanosoma cruzi. | Q35273171 | ||
| Cruzipain Activates Latent TGF-β from Host Cells during T. cruzi Invasion. | Q35621418 | ||
| Biochemical analysis of the membrane and soluble forms of the complement regulatory protein of Trypanosoma cruzi | Q35771684 | ||
| Introduction to Thematic Review Series: Phospholipases: Central Role in Lipid Signaling and Disease | Q35776610 | ||
| Molecular Characterization of a Novel Family of Trypanosoma cruzi Surface Membrane Proteins (TcSMP) Involved in Mammalian Host Cell Invasion. | Q35840717 | ||
| gp63 homologues in Trypanosoma cruzi: surface antigens with metalloprotease activity and a possible role in host cell infection. | Q36045498 | ||
| Structural features affecting trafficking, processing, and secretion of Trypanosoma cruzi mucins | Q36122262 | ||
| Vesicles from different Trypanosoma cruzi strains trigger differential innate and chronic immune responses | Q36326969 | ||
| Molecular basis of mammalian cell invasion by Trypanosoma cruzi | Q36419260 | ||
| Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity | Q37072124 | ||
| Development of protease inhibitors for protozoan infections | Q37315245 | ||
| Reversible cysteine protease inhibitors show promise for a Chagas disease cure | Q37544765 | ||
| A successful strategy for the recovering of active P21, an insoluble recombinant protein of Trypanosoma cruzi | Q37614927 | ||
| Review on Trypanosoma cruzi: Host Cell Interaction | Q37784694 | ||
| Secretion by Trypanosoma cruzi of a peptidyl-prolyl cis-trans isomerase involved in cell infection | Q37887045 | ||
| Vesicles as carriers of virulence factors in parasitic protozoan diseases | Q38034618 | ||
| Cell signaling during Trypanosoma cruzi invasion | Q38066485 | ||
| The Gp85 surface glycoproteins from Trypanosoma cruzi | Q38165062 | ||
| Mucin-like molecules form a negatively charged coat that protects Trypanosoma cruzi trypomastigotes from killing by human anti-alpha-galactosyl antibodies | Q38314745 | ||
| Cruzipain: An Update on its Potential as Chemotherapy Target against the Human Pathogen Trypanosoma cruzi | Q38494579 | ||
| Secreted trypanosome cyclophilin inactivates lytic insect defense peptides and induces parasite calcineurin activation and infectivity | Q39198765 | ||
| Trypanosoma cruzi uses macropinocytosis as an additional entry pathway into mammalian host cell | Q39271863 | ||
| Phosphorylation/inactivation of PTEN by Akt-independent PI3K signaling in retinal pigment epithelium | Q39464756 | ||
| Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease | Q39541839 | ||
| Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. | Q39870130 | ||
| Proteins anchored via glycosylphosphatidylinositol and solubilizing phospholipases in Trypanosoma cruzi | Q40479776 | ||
| Molecular, functional and structural properties of the prolyl oligopeptidase of Trypanosoma cruzi (POP Tc80), which is required for parasite entry into mammalian cells | Q40484418 | ||
| Analysis of cyclosporin A and a set of analogs as inhibitors of a T. cruzi cyclophilin by docking and molecular dynamics | Q40866353 | ||
| Plasma membrane vesicles isolated from epimastigote forms of trypanosoma cruzi | Q40975893 | ||
| Alteration of macrophage function by a Trypanosoma cruzi membrane mucin | Q41079691 | ||
| Fibronectin-degrading activity of Trypanosoma cruzi cysteine proteinase plays a role in host cell invasion | Q41721965 | ||
| A T. cruzi-secreted protein immunologically related to the complement component C9: evidence for membrane pore-forming activity at low pH. | Q41730283 | ||
| Lysosomal phospholipase A1 in Trypanosoma cruzi: an enzyme with a possible role in the pathogenesis of Chagas' disease | Q41961583 | ||
| Inhibition of host connective tissue growth factor expression: a novel Trypanosoma cruzi-mediated response | Q42470075 | ||
| Isolation and characterization of a novel insect defensin from Rhodnius prolixus, a vector of Chagas disease | Q42595408 | ||
| Trypanosoma cruzi exoantigen is a member of a 160 kDa gene family. | Q42689354 | ||
| Developmentally regulated, phospholipase C-mediated release of the major surface glycoprotein of amastigotes of Trypanosoma cruzi | Q42939016 | ||
| Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors | Q42944340 | ||
| A lipid-modified phosphoinositide-specific phospholipase C (TcPI-PLC) is involved in differentiation of trypomastigotes to amastigotes of Trypanosoma cruzi | Q43218641 | ||
| Molecular characterization of serine-, alanine-, and proline-rich proteins of Trypanosoma cruzi and their possible role in host cell infection | Q43254872 | ||
| Trypanosoma cruzi, the causative agent of Chagas disease, modulates interleukin-6-induced STAT3 phosphorylation via gp130 cleavage in different host cells. | Q43448689 | ||
| Inhibitors of the major cysteinyl proteinase (GP57/51) impair host cell invasion and arrest the intracellular development of Trypanosoma cruzi in vitro | Q43499829 | ||
| The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specific Ig secretion | Q43898130 | ||
| Phospholipase C gamma and ERK1/2 mitogen activated kinase pathways are differentially modulated by Trypanosoma cruzi during tissue invasion in human placenta | Q44115394 | ||
| Alternative activation and increase of Trypanosoma cruzi survival in murine macrophages stimulated by cruzipain, a parasite antigen. | Q44178074 | ||
| Different signaling pathways are involved in cardiomyocyte survival induced by a Trypanosoma cruzi glycoprotein. | Q44179298 | ||
| The Trypanosoma cruzi membrane glycoprotein AGC10 inhibits human lymphocyte activation by a mechanism preceding translation of both, interleukin-2 and its high-affinity receptor subunits | Q44239911 | ||
| Proteomic analysis of Trypanosoma cruzi secretome: characterization of two populations of extracellular vesicles and soluble proteins. | Q44316258 | ||
| Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages | Q44320782 | ||
| Novel PI 3-kinase-dependent mechanisms of trypanosome invasion and vacuole maturation | Q44522457 | ||
| Cruzipain, a major Trypanosoma cruzi antigen, promotes arginase-2 expression and survival of neonatal mouse cardiomyocytes | Q44588538 | ||
| The Trypanosoma cruzi membrane mucin AgC10 inhibits T cell activation and IL-2 transcription through L-selectin | Q45020481 | ||
| Chagasin, the endogenous cysteine-protease inhibitor of Trypanosoma cruzi, modulates parasite differentiation and invasion of mammalian cells | Q45267339 | ||
| Characterization of a 21kDa protein from Trypanosoma cruzi associated with mammalian cell invasion. | Q46642120 | ||
| Chagas disease 101. | Q47380364 | ||
| Phospholipase A1: a novel virulence factor in Trypanosoma cruzi | Q48041550 | ||
| Involvement of TSSA (trypomastigote small surface antigen) in Trypanosoma cruzi invasion of mammalian cells. | Q48051213 | ||
| Identification of a Trypanosoma cruzi antigen that is shed during the acute phase of Chagas' disease | Q48297061 | ||
| A novel phosphatidylinositol-phospholipase C of Trypanosoma cruzi that is lipid modified and activated during trypomastigote to amastigote differentiation. | Q52170643 | ||
| Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the human complement regulatory protein, decay-accelerating factor. | Q52445292 | ||
| Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response | Q57067411 | ||
| Trypanosoma cruzi:The Tc-85 Surface Glycoprotein Shed by Trypomastigotes Bears a Modified Glycosylphosphatidylinositol Anchor | Q57067539 | ||
| Trypanosoma cruzi: Shedding of surface antigens as membrane vesicles | Q57067573 | ||
| Correlation of tunicamycin-sensitive surface glycoproteins from Trypanosoma cruzi with parasite interiorization into mammalian cells | Q57067626 | ||
| Extracellular Microvesicles: The Need for Internationally Recognised Nomenclature and Stringent Purification Criteria | Q57091939 | ||
| A novel and basic mechanism of immunosuppression in Chagas' disease: Trypanosoma cruzi releases in vitro and in vivo a protein which induces T cell unresponsiveness through specific interaction with cysteine and glutathione | Q58843559 | ||
| Direct lysis of Trypanosoma cruzi: a novel effector mechanism of protection mediated by human anti-gal antibodies | Q58844845 | ||
| Immunisation with a major Trypanosoma cruzi antigen promotes pro-inflammatory cytokines, nitric oxide production and increases TLR2 expression | Q58844876 | ||
| Inhibitory effects of theTrypanosoma cruzi membrane glycoprotein AGC10 on the expression of IL-2 receptor chains and secretion of cytokines by subpopulations of activated human T lymphocytes | Q58869431 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Trypanosoma cruzi | Q150162 |
| P304 | page(s) | 388 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | Interactions between Trypanosoma cruzi Secreted Proteins and Host Cell Signaling Pathways | |
| P478 | volume | 7 |
| Q42369950 | A New Trick for a Conserved Enzyme: Mevalonate Kinase, a Glycosomal Enzyme, Can Be Secreted by Trypanosoma cruzi and Modulate Cell Invasion and Signaling. Is It Another Moonlighting Enzyme? |
| Q64282227 | A retrospective study on the influence of siblings' relatedness in Bolivian patients with chronic Chagas disease |
| Q40076997 | Astrocyte Apoptosis and HIV Replication Are Modulated in Host Cells Coinfected with Trypanosoma cruzi. |
| Q92135995 | B-1 Cells May Drive Macrophages Susceptibility to Trypanosoma cruzi Infection |
| Q91975356 | Circulating T Follicular Helper Cell Abnormalities Associated to Different Clinical Forms of Chronic Chagas Disease |
| Q99711499 | Comparative Analysis of the Secretome and Interactome of Trypanosoma cruzi and Trypanosoma rangeli Reveals Species Specific Immune Response Modulating Proteins |
| Q26740647 | Dendritic Cells: A Double-Edged Sword in Immune Responses during Chagas Disease |
| Q64121227 | Extracellular vesicles of Trypanosoma cruzi tissue-culture cell-derived trypomastigotes: Induction of physiological changes in non-parasitized culture cells |
| Q47551893 | Identification of Secreted Proteins Involved in Nonspecific dsRNA-Mediated Lutzomyia longipalpis LL5 Cell Antiviral Response. |
| Q38742667 | Macrophages Promote Oxidative Metabolism To Drive Nitric Oxide Generation in Response to Trypanosoma cruzi |
| Q38734916 | Non-coding RNAs in Host-Pathogen Interactions: Subversion of Mammalian Cell Functions by Protozoan Parasites |
| Q44174009 | Response to Trypanosoma cruzi by Human Blood Cells Enriched with Dentritic Cells Is Controlled by Cyclooxygenase-2 Pathway |
| Q40119715 | Role of Inactive and Active Trypanosoma cruzi Trans-sialidases on T Cell Homing and Secretion of Inflammatory Cytokines |
| Q39284836 | The Complement System: A Prey of Trypanosoma cruzi |
| Q53685684 | Trypanosomatid Infections: How Do Parasites and Their Excreted-Secreted Factors Modulate the Inducible Metabolism of l-Arginine in Macrophages? |
Search more.